TRCT
KOD icon

Tower Research Capital (TRC)’s Kodiak Sciences KOD Stock Holding History

Tower Research Capital (TRC)’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Sell
2,961
-2,537
-46% -$98.7K ﹤0.01% 2079
2026
Q1 		$210K Buy
5,498
+5,063
+1,164% +$131K 0.01% 1581
2025
Q4 		$12.2K Sell
435
-2,382
-85% -$48.8K ﹤0.01% 3510
2025
Q3 		$46.1K Sell
2,817
-3,668
-57% -$31.6K ﹤0.01% 2590
2025
Q2 		$24.2K Buy
6,485
+2,826
+77% +$10K ﹤0.01% 3572
2025
Q1 		$10.3K Buy
3,659
+1,950
+114% +$10.6K ﹤0.01% 3663
2024
Q4 		$17K Sell
1,709
-1,415
-45% -$8.13K ﹤0.01% 3330
2024
Q3 		$8.15K Sell
3,124
-11,513
-79% -$30.6K ﹤0.01% 3981
2024
Q2 		$34.4K Buy
14,637
+12,214
+504% +$41.4K ﹤0.01% 3382
2024
Q1 		$12.7K Sell
2,423
-8,425
-78% -$41.3K ﹤0.01% 3452
2023
Q4 		$33K Sell
10,848
-6,146
-36% -$13.7K ﹤0.01% 3367
2023
Q3 		$30.6K Buy
16,994
+15,660
+1,174% +$55.3K ﹤0.01% 3004
2023
Q2 		$9.2K Sell
1,334
-16,129
-92% -$98.6K ﹤0.01% 4320
2023
Q1 		$109K Sell
17,463
-4,379
-20% -$30.6K ﹤0.01% 1794
2022
Q4 		$156K Buy
21,842
+5,201
+31% +$37.3K 0.01% 1481
2022
Q3 		$129K Buy
16,641
+12,461
+298% +$121K ﹤0.01% 2332
2022
Q2 		$32K Buy
4,180
+2,805
+204% +$19.7K ﹤0.01% 3305
2022
Q1 		$11K Sell
1,375
-2,279
-62% -$88.9K ﹤0.01% 4182
2021
Q4 		$310K Buy
3,654
+2,471
+209% +$251K 0.01% 1456
2021
Q3 		$113K Sell
1,183
-627
-35% -$57.9K ﹤0.01% 2295
2021
Q2 		$168K Sell
1,810
-254
-12% -$24.4K ﹤0.01% 2047
2021
Q1 		$234K Buy
2,064
+531
+35% +$72.5K ﹤0.01% 1884
2020
Q4 		$225K Buy
1,533
+218
+17% +$24.3K 0.01% 1614
2020
Q3 		$78K Sell
1,315
-6,123
-82% -$307K ﹤0.01% 3323
2020
Q2 		$403K Buy
+7,438
New +$419K 0.02% 1204
2019
Q4 		– Sell
-494
Closed -$7K – 3972
2019
Q3 		$7K Buy
494
+458
+1,272% +$5.98K ﹤0.01% 3144
2019
Q2 		$0 Sell
36
-798
-96% -$7.1K ﹤0.01% 3989
2019
Q1 		$6K Buy
+834
New +$6.17K ﹤0.01% 2955

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Tower Research Capital (TRC)'s KOD Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Kodiak Sciences (KOD) stake by 46% in Q2 2026, selling an estimated $98.7K and leaving 2,961 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Tower Research Capital (TRC) first reported a position in KOD in Q1 2019 and has held it in 28 quarters since. The position peaked at $403K in Q2 2020. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Tower Research Capital (TRC) held 2,961 shares of Kodiak Sciences worth $115K as of Q2 2026.
  • Tower Research Capital (TRC) sold 2,537 Kodiak Sciences shares in Q2 2026, an estimated $98.7K.
  • Kodiak Sciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2079 holding.
  • Tower Research Capital (TRC) first reported a position in Kodiak Sciences in Q1 2019 and has held it in 28 quarters since.
  • Tower Research Capital (TRC)'s Kodiak Sciences position peaked at $403K in Q2 2020.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.